1. Home
  2. ITRM vs BEDU Comparison

ITRM vs BEDU Comparison

Compare ITRM & BEDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • BEDU
  • Stock Information
  • Founded
  • ITRM 2015
  • BEDU 1994
  • Country
  • ITRM Ireland
  • BEDU United Kingdom
  • Employees
  • ITRM N/A
  • BEDU N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • BEDU Other Consumer Services
  • Sector
  • ITRM Health Care
  • BEDU Real Estate
  • Exchange
  • ITRM Nasdaq
  • BEDU Nasdaq
  • Market Cap
  • ITRM 40.0M
  • BEDU 47.7M
  • IPO Year
  • ITRM 2018
  • BEDU 2017
  • Fundamental
  • Price
  • ITRM $0.94
  • BEDU $1.79
  • Analyst Decision
  • ITRM Strong Buy
  • BEDU
  • Analyst Count
  • ITRM 2
  • BEDU 0
  • Target Price
  • ITRM $7.00
  • BEDU N/A
  • AVG Volume (30 Days)
  • ITRM 534.3K
  • BEDU 3.4K
  • Earning Date
  • ITRM 08-13-2025
  • BEDU 08-01-2025
  • Dividend Yield
  • ITRM N/A
  • BEDU N/A
  • EPS Growth
  • ITRM N/A
  • BEDU N/A
  • EPS
  • ITRM N/A
  • BEDU N/A
  • Revenue
  • ITRM N/A
  • BEDU $224,321,752.00
  • Revenue This Year
  • ITRM N/A
  • BEDU N/A
  • Revenue Next Year
  • ITRM $270.19
  • BEDU N/A
  • P/E Ratio
  • ITRM N/A
  • BEDU N/A
  • Revenue Growth
  • ITRM N/A
  • BEDU N/A
  • 52 Week Low
  • ITRM $0.81
  • BEDU $1.35
  • 52 Week High
  • ITRM $3.02
  • BEDU $2.41
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 41.32
  • BEDU 53.41
  • Support Level
  • ITRM $0.91
  • BEDU $1.70
  • Resistance Level
  • ITRM $1.03
  • BEDU $1.90
  • Average True Range (ATR)
  • ITRM 0.04
  • BEDU 0.04
  • MACD
  • ITRM -0.01
  • BEDU 0.00
  • Stochastic Oscillator
  • ITRM 16.28
  • BEDU 56.00

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About BEDU Bright Scholar Education Holdings Limited each representing four

Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom (the UK) and the United States (the U.S.) Kingdom. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.

Share on Social Networks: